Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Maryam Asgari to Skin Neoplasms

This is a "connection" page, showing publications Maryam Asgari has written about Skin Neoplasms.

 
Connection Strength
  
 
 
22.514
  
  1. Choquet H, Jiang C, Yin J, Kim Y, Hoffmann TJ, Jorgenson E, Asgari MM. Multi-ancestry genome-wide meta-analysis identifies novel basal cell carcinoma loci and shared genetic effects with squamous cell carcinoma. Commun Biol. 2024 01 05; 7(1):33.
    View in: PubMed
    Score: 0.543
  2. Ashrafzadeh S, Foreman RK, Kalra S, Mandinova A, Asgari MM. Patterns of Tumor-Infiltrating Lymphocytes Used to Distinguish Primary Cutaneous Squamous Cell Carcinomas That Metastasize. JAMA Dermatol. 2023 07 01; 159(7):788-790.
    View in: PubMed
    Score: 0.524
  3. Asgari MM, Crane LA. Skin Cancer Screening: The Importance of Identifying High-risk Subgroups and the Need for US-Based Population Research. JAMA. 2023 04 18; 329(15):1259-1260.
    View in: PubMed
    Score: 0.517
  4. Kim Y, Yin J, Le Breton S, Jorgenson E, Huang H, Choquet H, Asgari MM. Genetically Predicted Serum Vitamin C Levels and Cutaneous Squamous Cell Carcinoma Risk. J Invest Dermatol. 2023 04; 143(4):664-667.
    View in: PubMed
    Score: 0.501
  5. Kim Y, Yin J, Huang H, Jorgenson E, Choquet H, Asgari MM. Genome-wide association study of actinic keratosis identifies new susceptibility loci implicated in pigmentation and immune regulation pathways. Commun Biol. 2022 04 21; 5(1):386.
    View in: PubMed
    Score: 0.483
  6. Jorgenson E, Choquet H, Yin J, Hoffmann TJ, Banda Y, Kvale MN, Risch N, Schaefer C, Asgari MM. Genetic ancestry, skin pigmentation, and the risk of cutaneous squamous cell carcinoma in Hispanic/Latino and non-Hispanic white populations. Commun Biol. 2020 12 14; 3(1):765.
    View in: PubMed
    Score: 0.440
  7. Yao Q, Epstein CB, Banskota S, Issner R, Kim Y, Bernstein BE, Pinello L, Asgari MM. Epigenetic Alterations in Keratinocyte Carcinoma. J Invest Dermatol. 2021 05; 141(5):1207-1218.
    View in: PubMed
    Score: 0.437
  8. Asgari MM, Tsai AL, Avalos L, Sokil M, Quesenberry CP. Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis. JAMA Dermatol. 2020 10 01; 156(10):1066-1073.
    View in: PubMed
    Score: 0.433
  9. Kim Y, Jorgenson E, Asgari MM. Developing a risk prediction model for keratinocyte carcinoma in patients with actinic keratosis. Br J Dermatol. 2020 09; 183(3):415-416.
    View in: PubMed
    Score: 0.422
  10. Chavez A, Quesenberry CP, Darbinian J, Asgari MM. Association of Valproic Acid Use, a Potent Histone Deacetylase Inhibitor, and Melanoma Risk. J Invest Dermatol. 2020 12; 140(12):2353-2358.
    View in: PubMed
    Score: 0.421
  11. Weintraub GS, Su KA, Demehri S, Asgari MM. Enhancing the process for care delivery in a dermatology specialty clinic. J Am Acad Dermatol. 2020 Oct; 83(4):1181-1184.
    View in: PubMed
    Score: 0.415
  12. Roberts MR, Sordillo JE, Kraft P, Asgari MM. Sex-Stratified Polygenic Risk Score Identifies Individuals at Increased Risk of Basal Cell Carcinoma. J Invest Dermatol. 2020 05; 140(5):971-975.
    View in: PubMed
    Score: 0.407
  13. Yeh I, Jorgenson E, Shen L, Xu M, North JP, Shain AH, Reuss D, Wu H, Robinson WA, Olshen A, von Deimling A, Kwok PY, Bastian BC, Asgari MM. Targeted Genomic Profiling of Acral Melanoma. J Natl Cancer Inst. 2019 10 01; 111(10):1068-1077.
    View in: PubMed
    Score: 0.404
  14. Kim Y, Su KA, Asgari MM. Correlates of multiple cutaneous squamous cell carcinoma: A retrospective cohort study. J Am Acad Dermatol. 2020 02; 82(2):497-499.
    View in: PubMed
    Score: 0.400
  15. Karas L, Lu CY, Agrawal PB, Asgari MM. The impact of the Orphan Drug Act on Food and Drug Administration-approved therapies for rare skin diseases and skin-related cancers. J Am Acad Dermatol. 2019 09; 81(3):867-877.
    View in: PubMed
    Score: 0.394
  16. Feng J, LaChance A, Sinclair DA, Asgari MM. Multiple basal cell carcinomas in a patient with myotonic dystrophy type 1. BMJ Case Rep. 2019 Mar 08; 12(3).
    View in: PubMed
    Score: 0.389
  17. Neugebauer R, Su KA, Zhu Z, Sokil M, Chren MM, Friedman GD, Asgari MM. Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A?cohort study. J Am Acad Dermatol. 2019 Apr; 80(4):998-1005.
    View in: PubMed
    Score: 0.381
  18. Su KA, Habel LA, Achacoso NS, Friedman GD, Asgari MM. Photosensitizing antihypertensive drug use and risk of cutaneous squamous cell carcinoma. Br J Dermatol. 2018 11; 179(5):1088-1094.
    View in: PubMed
    Score: 0.374
  19. Kim Y, Kraft P, Asgari MM. Using a Mendelian randomization approach to explore a causal relationship between vitamin D and nonmelanoma skin cancer. Br J Dermatol. 2018 06; 178(6):1241-1242.
    View in: PubMed
    Score: 0.369
  20. Wang W, Ollila HM, Whittemore AS, Demehri S, Ioannidis NM, Jorgenson E, Mignot E, Asgari MM. Genetic variants in the HLA class II region associated with risk of cutaneous squamous cell carcinoma. Cancer Immunol Immunother. 2018 Jul; 67(7):1123-1133.
    View in: PubMed
    Score: 0.367
  21. Jorgenson E, Choquet H, Yin J, Asgari MM. Common Mitochondrial Haplogroups and Cutaneous Squamous Cell Carcinoma Risk. Cancer Epidemiol Biomarkers Prev. 2018 07; 27(7):838-841.
    View in: PubMed
    Score: 0.366
  22. Sordillo JE, Kraft P, Wu AC, Asgari MM. Quantifying the Polygenic Contribution to Cutaneous Squamous Cell Carcinoma Risk. J Invest Dermatol. 2018 07; 138(7):1507-1510.
    View in: PubMed
    Score: 0.361
  23. Wang W, Jorgenson E, Whittemore AS, Asgari MM. Susceptibility Loci-Associated Cutaneous Squamous Cell Carcinoma Invasiveness. J Invest Dermatol. 2018 03; 138(3):557-561.
    View in: PubMed
    Score: 0.353
  24. Asgari MM, Ray GT, Quesenberry CP, Katz KA, Silverberg MJ. Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load. JAMA Dermatol. 2017 09 01; 153(9):892-896.
    View in: PubMed
    Score: 0.350
  25. Asgari MM, Shen L, Sokil MM, Yeh I, Jorgenson E. Prognostic factors and survival in acral lentiginous melanoma. Br J Dermatol. 2017 Aug; 177(2):428-435.
    View in: PubMed
    Score: 0.348
  26. Asgari MM, Chien AJ, Tsai AL, Fireman B, Quesenberry CP. Association between Lithium Use and?Melanoma Risk and Mortality: A?Population-Based Study. J Invest Dermatol. 2017 10; 137(10):2087-2091.
    View in: PubMed
    Score: 0.345
  27. Yesantharao P, Wang W, Ioannidis NM, Demehri S, Whittemore AS, Asgari MM. Cutaneous squamous cell cancer (cSCC) risk and the human leukocyte antigen (HLA) system. Hum Immunol. 2017 Apr; 78(4):327-335.
    View in: PubMed
    Score: 0.337
  28. Asgari MM, Ray GT, Geier JL, Quesenberry CP. Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population. J Am Acad Dermatol. 2017 Apr; 76(4):632-638.
    View in: PubMed
    Score: 0.336
  29. Ray GT, Kulldorff M, Asgari MM. Geographic Clusters of Basal Cell Carcinoma in a Northern California Health Plan Population. JAMA Dermatol. 2016 11 01; 152(11):1218-1224.
    View in: PubMed
    Score: 0.330
  30. Asgari MM. Utility and Limitations of Large Population-Based Data for Skin Cancer Outcomes. J Invest Dermatol. 2016 11; 136(11):2128-2130.
    View in: PubMed
    Score: 0.330
  31. Whittemore AS, Wang W, Jorgenson E, Asgari MM. A GWAS of Cutaneous Squamous Cell Carcinoma-Letter. Cancer Epidemiol Biomarkers Prev. 2016 11; 25(11):1534.
    View in: PubMed
    Score: 0.330
  32. Asgari MM, Toland AE, Arron ST. IRF4 Polymorphism Is Associated with Cutaneous Squamous Cell Carcinoma in?Organ Transplant Recipients: A Pigment-Independent Phenomenon. J Invest Dermatol. 2017 01; 137(1):251-253.
    View in: PubMed
    Score: 0.326
  33. Asgari MM, Wang W, Ioannidis NM, Itnyre J, Hoffmann T, Jorgenson E, Whittemore AS. Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma. J Invest Dermatol. 2016 05; 136(5):930-937.
    View in: PubMed
    Score: 0.313
  34. Asgari MM, Moffet HH, Ray GT, Quesenberry CP. Trends in Basal Cell Carcinoma Incidence and Identification of High-Risk Subgroups, 1998-2012. JAMA Dermatol. 2015 Sep; 151(9):976-81.
    View in: PubMed
    Score: 0.305
  35. Moore MM, Geller AC, Warton EM, Schwalbe J, Asgari MM. Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011. J Am Acad Dermatol. 2015 Oct; 73(4):630-6.
    View in: PubMed
    Score: 0.304
  36. Asgari MM, Arron ST, Warton EM, Quesenberry CP, Weisshaar D. Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant?recipients (SOTRs). J Am Acad Dermatol. 2015 Sep; 73(3):444-50.
    View in: PubMed
    Score: 0.301
  37. Asgari MM, Warton EM, Whittemore AS. Family history of skin cancer is associated with increased risk of cutaneous squamous cell carcinoma. Dermatol Surg. 2015 Apr; 41(4):481-6.
    View in: PubMed
    Score: 0.296
  38. Asgari MM, Eide MJ, Warton M, Fletcher SW. Comparing characteristics of melanoma cases arising in health maintenance organizations with state and national registries. Melanoma Res. 2014 Aug; 24(4):381-7.
    View in: PubMed
    Score: 0.283
  39. Asgari MM, Sokil MM, Warton EM, Iyer J, Paulson KG, Nghiem P. Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma. JAMA Dermatol. 2014 Jul; 150(7):716-23.
    View in: PubMed
    Score: 0.281
  40. Asgari MM, Warton EM, Quesenberry CP, Koralek DO, Taylor M. Risk of subsequent cutaneous squamous cell carcinoma in patients with melanoma. J Am Acad Dermatol. 2014 Sep; 71(3):521-8.
    View in: PubMed
    Score: 0.279
  41. Asgari M, Chen S. Papillary eccrine adenoma should not be mistaken for aggressive digital papillary adenocarcinoma. Clin Exp Dermatol. 2014 Mar; 39(2):223-4.
    View in: PubMed
    Score: 0.270
  42. Silverberg MJ, Leyden W, Warton EM, Quesenberry CP, Engels EA, Asgari MM. HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst. 2013 Mar 06; 105(5):350-60.
    View in: PubMed
    Score: 0.253
  43. Asgari MM, Eide MJ, Warton EM, Fletcher SW. Validation of a large basal cell carcinoma registry. J Registry Manag. 2013; 40(2):65-9.
    View in: PubMed
    Score: 0.253
  44. Tang JY, Fu T, Lau C, Oh DH, Bikle DD, Asgari MM. Vitamin D in cutaneous carcinogenesis: part I. J Am Acad Dermatol. 2012 Nov; 67(5):803.e1-12, quiz 815-6.
    View in: PubMed
    Score: 0.250
  45. Tang JY, Fu T, Lau C, Oh DH, Bikle DD, Asgari MM. Vitamin D in cutaneous carcinogenesis: part II. J Am Acad Dermatol. 2012 Nov; 67(5):817.e1-11; quiz 827-8.
    View in: PubMed
    Score: 0.250
  46. Asgari MM, Brasky TM, White E. Association of vitamin A and carotenoid intake with melanoma risk in a large prospective cohort. J Invest Dermatol. 2012 Jun; 132(6):1573-82.
    View in: PubMed
    Score: 0.239
  47. Olson JM, Alam M, Asgari MM. Needs assessment for general dermatologic surgery. Dermatol Clin. 2012 Jan; 30(1):153-66, x.
    View in: PubMed
    Score: 0.236
  48. Asgari MM, Olson JM, Alam M. Needs assessment for Mohs micrographic surgery. Dermatol Clin. 2012 Jan; 30(1):167-75, x.
    View in: PubMed
    Score: 0.236
  49. Asgari MM, Warton EM, Neugebauer R, Chren MM. Predictors of patient satisfaction with Mohs surgery: analysis of preoperative, intraoperative, and postoperative factors in a prospective cohort. Arch Dermatol. 2011 Dec; 147(12):1387-94.
    View in: PubMed
    Score: 0.235
  50. Asgari MM, Chren MM, Warton EM, Friedman GD, White E. Supplement use and risk of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2011 Dec; 65(6):1145-51.
    View in: PubMed
    Score: 0.227
  51. Asgari MM, White E, Warton EM, Hararah MK, Friedman GD, Chren MM. Association of tea consumption and cutaneous squamous cell carcinoma. Nutr Cancer. 2011; 63(2):314-8.
    View in: PubMed
    Score: 0.221
  52. Asgari MM, Chren MM, Warton EM, Friedman GD, White E. Association between nonsteroidal anti-inflammatory drug use and cutaneous squamous cell carcinoma. Arch Dermatol. 2010 Apr; 146(4):388-95.
    View in: PubMed
    Score: 0.208
  53. Asgari MM, Efird JT, Warton EM, Friedman GD. Potential risk factors for cutaneous squamous cell carcinoma include oral contraceptives: results of a nested case-control study. Int J Environ Res Public Health. 2010 02; 7(2):427-42.
    View in: PubMed
    Score: 0.207
  54. Asgari MM, Tang J, Warton ME, Chren MM, Quesenberry CP, Bikle D, Horst RL, Orentreich N, Vogelman JH, Friedman GD. Association of prediagnostic serum vitamin D levels with the development of basal cell carcinoma. J Invest Dermatol. 2010 May; 130(5):1438-43.
    View in: PubMed
    Score: 0.206
  55. Asgari MM, Maruti SS, Kushi LH, White E. Antioxidant supplementation and risk of incident melanomas: results of a large prospective cohort study. Arch Dermatol. 2009 Aug; 145(8):879-82.
    View in: PubMed
    Score: 0.200
  56. Asgari MM, Bertenthal D, Sen S, Sahay A, Chren MM. Patient satisfaction after treatment of nonmelanoma skin cancer. Dermatol Surg. 2009 Jul; 35(7):1041-9.
    View in: PubMed
    Score: 0.197
  57. Asgari MM, Maruti SS, Kushi LH, White E. A cohort study of vitamin D intake and melanoma risk. J Invest Dermatol. 2009 Jul; 129(7):1675-80.
    View in: PubMed
    Score: 0.193
  58. Asgari MM, Maruti SS, White E. A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence. J Natl Cancer Inst. 2008 Jul 02; 100(13):967-71.
    View in: PubMed
    Score: 0.185
  59. Asgari MM, Kiviat NB, Critchlow CW, Stern JE, Argenyi ZB, Raugi GJ, Berg D, Odland PB, Hawes SE, de Villiers EM. Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals. J Invest Dermatol. 2008 Jun; 128(6):1409-17.
    View in: PubMed
    Score: 0.179
  60. Asgari M, White E, Chren MM. Nonsteroidal anti-inflammatory drug use in the prevention and treatment of squamous cell carcinoma. Dermatol Surg. 2004 Oct; 30(10):1335-42.
    View in: PubMed
    Score: 0.143
  61. Asgari M, Rubin BP, Hornung RL. Neonate with a fibrosarcoma and consumptive coagulopathy. J Am Acad Dermatol. 2004 Feb; 50(2 Suppl):S23-5.
    View in: PubMed
    Score: 0.137
  62. Wan G, Leung BW, DeSimone MS, Nguyen N, Rajeh A, Collier MR, Rashdan H, Roster K, Zhou X, Moseley CB, Nirmal AJ, Pelletier RJ, Maliga Z, Marko-Varga G, N?meth IB, Tsao H, Asgari MM, Gusev A, Stagner AM, Lian CG, Hurlbert MS, Liu F, Yu KH, Sorger PK, Semenov YR. Development and validation of time-to-event models to predict metastatic recurrence of localized cutaneous melanoma. J Am Acad Dermatol. 2024 02; 90(2):288-298.
    View in: PubMed
    Score: 0.133
  63. Azin M, Ameri AH, Nazarian RM, Cusack JC, Tsiaras WG, Asgari MM, Demehri S. Treatment of an Unresectable Cutaneous Squamous Cell Carcinoma With ED&C and 5-FU. Cutis. 2023 07; 112(1):E27-E29.
    View in: PubMed
    Score: 0.131
  64. Hedderson MM, Asgari MM, Xu F, Quesenberry CP, Sridhar S, Geier J, Lemeshow AR. Rates of malignancies among patients with moderate to severe atopic dermatitis: a retrospective cohort study. BMJ Open. 2023 03 10; 13(3):e071172.
    View in: PubMed
    Score: 0.128
  65. Nguyen N, Wan G, Ugwu-Dike P, Alexander NA, Raval N, Zhang S, Jairath R, Phillipps J, Leung B, Roster K, Seo J, Lu C, Tang K, Choi MS, DeSimone MS, Theodosakis N, Amadife M, Cox N, Le TK, Liu F, Chen W, Bai X, Boland G, Liu D, Hurlbert MS, LeBoeuf N, Reynolds KL, Yu KH, Tsao H, Asgari M, Gusev A, Kwatra SG, Semenov YR. Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy. J Am Acad Dermatol. 2023 06; 88(6):1308-1316.
    View in: PubMed
    Score: 0.128
  66. Raval NS, Hodges WT, Ugwu-Dike PO, Godoy F, Ansstas G, Cornelius LA, Musiek AC, Asgari MM, Semenov YR. Racial and socioeconomic differences in acral lentiginous melanoma outcomes: A Surveillance, Epidemiology, and End Results analysis. J Am Acad Dermatol. 2022 10; 87(4):866-867.
    View in: PubMed
    Score: 0.117
  67. Massey PR, Schmults CD, Li SJ, Arron ST, Asgari MM, Bouwes Bavinck JN, Billingsley E, Blalock TW, Blasdale K, Carroll BT, Carucci JA, Chong AH, Christensen SR, Chung CL, DeSimone JA, Ducroux E, Escutia-Mu?oz B, Ferr?ndiz-Pulido C, Fox MC, Genders RE, Geusau A, Gjersvik P, Hanlon AM, Olasz Harken EB, Hofbauer GFL, Hopkins RS, Leitenberger JJ, Loss MJ, Del Marmol V, Mascar? JM, Myers SA, Nguyen BT, Oliveira WRP, Otley CC, Proby CM, R?cz E, Ruiz-Salas V, Samie FH, Se?kin D, Shah SN, Shin TM, Shumack SP, Soon SL, Stasko T, Zavattaro E, Zeitouni NC, Zwald FO, Harwood CA, Jambusaria-Pahlajani A. Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement. JAMA Dermatol. 2021 Oct 01; 157(10):1219-1226.
    View in: PubMed
    Score: 0.116
  68. Choquet H, Ashrafzadeh S, Kim Y, Asgari MM, Jorgenson E. Genetic and environmental factors underlying keratinocyte carcinoma risk. JCI Insight. 2020 05 21; 5(10).
    View in: PubMed
    Score: 0.106
  69. Strickley JD, Messerschmidt JL, Awad ME, Li T, Hasegawa T, Ha DT, Nabeta HW, Bevins PA, Ngo KH, Asgari MM, Nazarian RM, Neel VA, Jenson AB, Joh J, Demehri S. Immunity to commensal papillomaviruses protects against skin cancer. Nature. 2019 11; 575(7783):519-522.
    View in: PubMed
    Score: 0.102
  70. Ameri AH, Mooradian MJ, Emerick KS, Park JC, Wirth LJ, Asgari MM, Tsao H, Lawrence D, Sullivan RJ, Demehri S. Immunotherapeutic strategies for cutaneous squamous cell carcinoma prevention in xeroderma pigmentosum. Br J Dermatol. 2019 11; 181(5):1095-1097.
    View in: PubMed
    Score: 0.100
  71. Roberts MR, Asgari MM, Toland AE. Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet? Br J Dermatol. 2019 12; 181(6):1146-1155.
    View in: PubMed
    Score: 0.099
  72. Ioannidis NM, Wang W, Furlotte NA, Hinds DA, Bustamante CD, Jorgenson E, Asgari MM, Whittemore AS. Gene expression imputation identifies candidate genes and susceptibility loci associated with cutaneous squamous cell carcinoma. Nat Commun. 2018 10 15; 9(1):4264.
    View in: PubMed
    Score: 0.095
  73. Feng J, Kim Y, Kornides ML, McRee AL, Mays D, Asgari MM, Gilkey MB. Correlates of positive parental attitudes towards adolescent indoor tanning in the U.S.A. Br J Dermatol. 2018 12; 179(6):1412-1413.
    View in: PubMed
    Score: 0.094
  74. Wang W, Jorgenson E, Ioannidis NM, Asgari MM, Whittemore AS. A Prediction Tool to Facilitate Risk-Stratified Screening for Squamous?Cell?Skin Cancer. J Invest Dermatol. 2018 12; 138(12):2589-2594.
    View in: PubMed
    Score: 0.093
  75. Tang H, Fu S, Zhai S, Song Y, Asgari MM, Han J. Use of antihypertensive drugs and risk of keratinocyte carcinoma: A meta-analysis of observational studies. Pharmacoepidemiol Drug Saf. 2018 03; 27(3):279-288.
    View in: PubMed
    Score: 0.090
  76. Blomberg M, He SY, Harwood C, Arron ST, Demehri S, Green A, Asgari MM. Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients. Br J Dermatol. 2017 Nov; 177(5):1225-1233.
    View in: PubMed
    Score: 0.088
  77. Nguyen MO, Nguyen HT, Asgari MM. Towards the use of precision medicine in predicting cutaneous squamous cell carcinoma risk among solid organ transplant recipients. Br J Dermatol. 2017 10; 177(4):901-902.
    View in: PubMed
    Score: 0.088
  78. Lowenstein SE, Garrett G, Toland AE, Jambusaria-Pahlajani A, Asgari MM, Green A, Engels EA, Arron ST. Risk prediction tools for keratinocyte carcinoma after solid organ transplantation: a review of the literature. Br J Dermatol. 2017 Nov; 177(5):1202-1207.
    View in: PubMed
    Score: 0.088
  79. Jiang AJ, Eide MJ, Alexander GL, Altschuler A, Asgari MM, Geller AC, Fletcher SW, Halpern AC, Weinstock MA. Providers' Experiences with a Melanoma Web-Based Course: a Discussion on Barriers and Intentions. J Cancer Educ. 2017 Jun; 32(2):272-279.
    View in: PubMed
    Score: 0.086
  80. Moshiri AS, Doumani R, Yelistratova L, Blom A, Lachance K, Shinohara MM, Delaney M, Chang O, McArdle S, Thomas H, Asgari MM, Huang ML, Schwartz SM, Nghiem P. Polyomavirus-Negative Merkel Cell Carcinoma: A More Aggressive Subtype Based on Analysis of 282 Cases Using Multimodal Tumor Virus Detection. J Invest Dermatol. 2017 04; 137(4):819-827.
    View in: PubMed
    Score: 0.083
  81. Iyer JG, Parvathaneni K, Bhatia S, Tarabadkar ES, Blom A, Doumani R, McKenzie J, Asgari MM, Nghiem P. Paraneoplastic syndromes (PNS) associated with Merkel cell carcinoma (MCC): A case series of 8 patients highlighting different clinical manifestations. J Am Acad Dermatol. 2016 Sep; 75(3):541-547.
    View in: PubMed
    Score: 0.080
  82. Mansh M, Binstock M, Williams K, Hafeez F, Kim J, Glidden D, Boettger R, Hays S, Kukreja J, Golden J, Asgari MM, Chin-Hong P, Singer JP, Arron ST. Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients. Am J Transplant. 2016 Jan; 16(1):262-70.
    View in: PubMed
    Score: 0.076
  83. Paulson KG, Iyer JG, Simonson WT, Blom A, Thibodeau RM, Schmidt M, Pietromonaco S, Sokil M, Warton EM, Asgari MM, Nghiem P. CD8+ lymphocyte intratumoral infiltration as a stage-independent predictor of Merkel cell carcinoma survival: a population-based study. Am J Clin Pathol. 2014 Oct; 142(4):452-8.
    View in: PubMed
    Score: 0.071
  84. Eide MJ, Asgari MM, Fletcher SW, Geller AC, Halpern AC, Shaikh WR, Li L, Alexander GL, Altschuler A, Dusza SW, Marghoob AA, Quigley EA, Weinstock MA. Effects on skills and practice from a web-based skin cancer course for primary care providers. J Am Board Fam Med. 2013 Nov-Dec; 26(6):648-57.
    View in: PubMed
    Score: 0.067
  85. Shaikh WR, Geller A, Alexander G, Asgari MM, Chanange GJ, Dusza S, Eide MJ, Fletcher SW, Goulart JM, Halpern AC, Landow S, Marghoob AA, Quigley EA, Weinstock MA. Developing an interactive web-based learning program on skin cancer: the learning experiences of clinical educators. J Cancer Educ. 2012 Dec; 27(4):709-16.
    View in: PubMed
    Score: 0.063
  86. Paulson KG, Iyer JG, Blom A, Warton EM, Sokil M, Yelistratova L, Schuman L, Nagase K, Bhatia S, Asgari MM, Nghiem P. Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage. J Invest Dermatol. 2013 Mar; 133(3):642-646.
    View in: PubMed
    Score: 0.063
  87. Loeb KR, Asgari MM, Hawes SE, Feng Q, Stern JE, Jiang M, Argenyi ZB, de Villiers EM, Kiviat NB. Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas. PLoS One. 2012; 7(4):e34422.
    View in: PubMed
    Score: 0.060
  88. Wilson LS, Pregenzer M, Basu R, Bertenthal D, Torres J, Asgari M, Chren MM. Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting. Dermatol Surg. 2012 Apr; 38(4):570-84.
    View in: PubMed
    Score: 0.059
  89. Bowen DJ, Hay JL, Mayer J, Kuniyuki A, Meischke H, Harris J, Asgari M, Shoveller J, Press N, Burke W. Predictors of recruited melanoma families into a behavioral intervention project. Contemp Clin Trials. 2012 Jan; 33(1):85-92.
    View in: PubMed
    Score: 0.058
  90. Goulart JM, Quigley EA, Dusza S, Jewell ST, Alexander G, Asgari MM, Eide MJ, Fletcher SW, Geller AC, Marghoob AA, Weinstock MA, Halpern AC. Skin cancer education for primary care physicians: a systematic review of published evaluated interventions. J Gen Intern Med. 2011 Sep; 26(9):1027-35.
    View in: PubMed
    Score: 0.056
  91. Harris JN, Hay J, Kuniyuki A, Asgari MM, Press N, Bowen DJ. Using a family systems approach to investigate cancer risk communication within melanoma families. Psychooncology. 2010 Oct; 19(10):1102-11.
    View in: PubMed
    Score: 0.054
  92. Tang JY, Wu A, Linos E, Parimi N, Lee W, Aszterbaum M, Asgari MM, Bickers DR, Epstein EH. High prevalence of vitamin D deficiency in patients with basal cell nevus syndrome. Arch Dermatol. 2010 Oct; 146(10):1105-10.
    View in: PubMed
    Score: 0.054
  93. Eide MJ, Krajenta R, Johnson D, Long JJ, Jacobsen G, Asgari MM, Lim HW, Johnson CC. Identification of patients with nonmelanoma skin cancer using health maintenance organization claims data. Am J Epidemiol. 2010 Jan 01; 171(1):123-8.
    View in: PubMed
    Score: 0.051
  94. Leachman SA, Carucci J, Kohlmann W, Banks KC, Asgari MM, Bergman W, Bianchi-Scarr? G, Brentnall T, Bressac-de Paillerets B, Bruno W, Curiel-Lewandrowski C, de Snoo FA, Debniak T, Demierre MF, Elder D, Goldstein AM, Grant-Kels J, Halpern AC, Ingvar C, Kefford RF, Lang J, MacKie RM, Mann GJ, Mueller K, Newton-Bishop J, Olsson H, Petersen GM, Puig S, Rigel D, Swetter SM, Tucker MA, Yakobson E, Zitelli JA, Tsao H. Selection criteria for genetic assessment of patients with familial melanoma. J Am Acad Dermatol. 2009 Oct; 61(4):677.e1-14.
    View in: PubMed
    Score: 0.051
  95. Sarin KY, Lin Y, Daneshjou R, Ziyatdinov A, Thorleifsson G, Rubin A, Pardo LM, Wu W, Khavari PA, Uitterlinden A, Nijsten T, Toland AE, Olafsson JH, Sigurgeirsson B, Thorisdottir K, Jorgensen E, Whittemore AS, Kraft P, Stacey SN, Stefansson K, Asgari MM, Han J. Genome-wide meta-analysis identifies eight new susceptibility loci for cutaneous squamous cell carcinoma. Nat Commun. 2020 02 10; 11(1):820.
    View in: PubMed
    Score: 0.026
  96. Harwood CA, Arron ST, Proby CM, Asgari MM, Bouwes Bavinck JN, Green AC, Toland AE. Organ transplantation and cutaneous squamous cell carcinoma: progress, pitfalls and priorities in immunosuppression-associated keratinocyte carcinoma. Br J Dermatol. 2017 11; 177(5):1150-1151.
    View in: PubMed
    Score: 0.022
  97. Gamba CA, Swetter SM, Stefanick ML, Kubo J, Desai M, Spaunhurst KM, Sinha AA, Asgari MM, Sturgeon S, Tang JY. Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: the Women's Health Initiative. Cancer. 2013 Apr 15; 119(8):1562-9.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)